Clinical Trials Directory

Trials / Completed

CompletedNCT02986074

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will compare therapeutic efficacy of a novel spinal cord stimulation leads implant based on anatomical landmarks with standard surgical implantation technique.

Detailed description

The primary purpose of this study is to compare the therapeutic efficacy of the conventional, paresthesia mapping-based burst spinal cord stimulation (SCS) implantation strategy to a more novel, anatomic midline-based approach that has the potential to streamline the workflow associated with the SCS treatment continuum.

Conditions

Interventions

TypeNameDescription
DEVICEParesthesia mapping lead evaluation firstSubjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using paresthesia mapping in the first part of the SCS trial and using the lead implanted using anatomical midline placement in the second part of the SCS trial
DEVICEAnatomical midline lead evaluation firstSubjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using anatomical midline in the first part of the SCS trial and using the lead implanted using paresthesia mapping placement in the second part of the SCS trial

Timeline

Start date
2016-11-01
Primary completion
2019-08-19
Completion
2019-08-19
First posted
2016-12-08
Last updated
2021-05-03
Results posted
2021-05-03

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02986074. Inclusion in this directory is not an endorsement.